Innovation Zed Publicizes CE Mark of New Expertise

Innovation Zed Publicizes CE Mark of New Expertise

DUBLIN, Feb. 20, 2023 (GLOBE NEWSWIRE) — Innovation Zed, an Irish R&D firm specialising within the design, growth and manufacturing of medical applied sciences, introduced at present it has secured a CE Mark for the InsulCheck DOSE add-on machine. As a pacesetter in related and good drug supply applied sciences, this certification showcases our dedication to assembly related well being, security, and environmental necessities concerning shopper security within the European Union (EU). It additionally opens the door for industrial enlargement inside Europe for the rising firm.

InsulCheck DOSE is a single-unit add-on machine for pen injectors that robotically captures dose worth dialled, injection occasion time stamp and temperature in addition to mounting and unmounting occasions. With InsulCheck DOSE, real-time injection occasion knowledge are logged and despatched robotically to a suitable show machine. Product highlights embody:

  • A discreet add-on machine suitable with all pen-injectors
  • Captures dose dialled, timestamp, ambient temperature, and so on.
  • A handy machine with no buttons, no calibration necessities or interference with the conventional injection course of
  • Elevated consumer engagement by means of high-quality usability help options from a vibrant OLED display

Innovation Zed is devoted to serving to insulin pen customers inside the diabetes inhabitants. Given our understanding of the challenges confronted by insulin pen customers worldwide, our focus is to help all insulin pen customers no matter their injection pen of alternative. Because of a collaboration with our associate SHL Medical and its subsidiary SHL Applied sciences, InsulCheck DOSE has been developed to satisfy the compatibility challenges offered by numerous injection pen designs and particularly the difficulties in engaged on a expertise to reliably and precisely help low-cost disposable pens. 

Dr Dean Minnock, CEO of Innovation Zed, mentioned, “InsulCheck DOSE is a third-generation product of the InsulCheck household and probably the most clever and suitable evolution of the InsulCheck platform. InsulCheck DOSE offers knowledge that, when utilized accurately, facilitates an evidence-driven strategy to precision insulin administration and considerably helps folks with diabetes make extra knowledgeable selections for his or her private remedy plan. Our InsulCheck DOSE helps all insulin pens with out altering the usability of the pen in any approach and with out interfering within the regular injection course of. In securing the CE mark for InsulCheck DOSE we reached an unimaginable milestone for our firm and for folks dwelling with diabetes in Europe.”

Innovation Zed expects to provoke a industrial launch of InsulCheck DOSE in Europe throughout 2023. The corporate additionally has plans to introduce bespoke variations of InsulCheck DOSE to new injection units for numerous drug therapies over the approaching years.

About Innovation Zed

Innovation Zed, Ltd. empowers folks to take management of diabetes by means of related expertise for insulin injection pens. Headquartered in Dublin, Eire, Innovation Zed has emerged as a pacesetter in injection pen expertise. By listening to the wants of customers, caregivers, and suppliers, Innovation Zed simplifies and improves diabetes administration all over the world. For extra details about InsulCheck DOSE go to

Contact Data:
Andrew Fitzpatrick
Analysis and Improvements Supervisor
[email protected]

Dean Minnock
[email protected]

Associated Photos

Innovation Zed Publicizes CE Mark of New Expertise

Picture 1: InsulCheck DOSE by Innovation Zed

InsulCheck DOSE robotically captures dose dialled and time since final injection

This content material was issued by means of the press launch distribution service at

  • InsulCheck DOSE by Innovation Zed